Evidence map›Paper›PMID 34796318›Full record

ReviewFrontiers in artificial intelligence2021

What Makes Artificial Intelligence Exceptional in Health Technology Assessment?

Jean-Christophe Bélisle-Pipon, Vincent Couture, Marie-Christine Roy, Isabelle Ganache, Mireille Goetghebeur, I Glenn Cohen

Abstract readReview
In one paragraph

Review in Frontiers in artificial intelligence, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Integrating ethical analysis in health technology assessment: opportunities and challenges.International journal of technology assessment in health care · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Health technology assessment framework for artificial intelligence-based technologies.International journal of technology assessment in health care · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Ethics dumping in artificial intelligence.Frontiers in artificial intelligence · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jean-Christophe Bélisle-PiponFaculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
Vincent CoutureFaculty of Nursing, Laval University, Quebec, QC, Canada.
Marie-Christine RoyÉcole de Santé Publique, Université de Montréal, Québec, QC, Canada.
Isabelle GanacheInstitut National D'Excellence en Santé et en Services Sociaux (INESSS), Montréal, Québec, QC, Canada.
Mireille GoetghebeurInstitut National D'Excellence en Santé et en Services Sociaux (INESSS), Montréal, Québec, QC, Canada.
I Glenn CohenHarvard Law School, Cambridge, MA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The application of artificial intelligence (AI) may revolutionize the healthcare system, leading to enhance efficiency by automatizing routine tasks and decreasing health-related costs, broadening access to healthcare delivery, targeting more precisely patient needs, and assisting clinicians in their decision-making. For these benefits to materialize, governments and health authorities must regulate AI, and conduct appropriate health technology assessment (HTA). Many authors have highlighted that AI health technologies (AIHT) challenge traditional evaluation and regulatory processes. To inform and support HTA organizations and regulators in adapting their processes to AIHTs, we conducted a systematic review of the literature on the challenges posed by AIHTs in HTA and health regulation. Our research question was: What makes artificial intelligence exceptional in HTA? The current body of literature appears to portray AIHTs as being exceptional to HTA. This exceptionalism is expressed along 5 dimensions: 1) AIHT's distinctive features; 2) their systemic impacts on health care and the health sector; 3) the increased expectations towards AI in health; 4) the new ethical, social and legal challenges that arise from deploying AI in the health sector; and 5) the new evaluative constraints that AI poses to HTA. Thus, AIHTs are perceived as exceptional because of their technological characteristics

Indexed as

artificial intelligenceethicalexceptionalismhealth regulationhealth technology assessmentsocial and legal implications

Identifiers

PMID34796318
PMCPMC8594317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.